Situation of Antiretroviral Drug Use in Nigeria, November 2003
(2003; 43 pages)

Abstract

Nigeria currently has an estimated 3.5 million People Living With HIV/AIDS (PLWHAs) and HIV seroprevalence level of 5.0%. In January 2002, the Nigerian government commenced a programme to provide antiretroviral (ARV) drugs, at a subsidized rate, to ten thousand (10,000) People Living with HIV/AIDS, annually. The objective of this study was to conduct a rapid assessment of the use and management of ARV drugs in the treatment centres. The assessment was aimed at identifying pressing issues in program management that could hinder the achievement of ensuring the uninterrupted supply of good quality ARVs. In essence, the result of the study was to form the basis for management decision-making and re-engineering of the ARV drug programme. Using questionnaires as a tool for measuring indicators (structural, process and outcome indicators), data was collected from designated treatment centres in public health facilities. Patients and health managers were also interviewed at the 25 treatment centres established by the government...

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014